Product Code: ETC5632978 | Publication Date: Nov 2023 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
Neurostimulation devices deliver electrical or magnetic impulses to specific nerves or brain regions to modulate neural activity and treat neurological disorders such as chronic pain, depression, and movement disorders. This market involves the manufacturing and distribution of neurostimulation implants and external devices.
The Israel neurostimulation market is experiencing robust growth driven by the increasing adoption of neuromodulation therapies for the treatment of neurological and psychiatric disorders. Neurostimulation devices deliver electrical or magnetic pulses to specific nerves or brain regions to modulate neural activity and alleviate symptoms associated with conditions such as chronic pain, movement disorders, depression, and epilepsy. With the growing prevalence of these disorders and the limitations of pharmacological treatments, there is a rising demand for innovative neurostimulation technologies that offer targeted and personalized therapeutic interventions. Israel strong expertise in medical technology innovation, coupled with its collaborative ecosystem of clinicians, researchers, and industry players, fosters the development of cutting-edge neurostimulation devices and positions the country as a leader in this rapidly evolving field.
In the Israel Neurostimulation market, challenges primarily revolve around regulatory approval and market adoption. Neurostimulation therapies, such as deep brain stimulation and spinal cord stimulation, offer promising treatment options for various neurological and psychiatric disorders. However, gaining regulatory approval for new neurostimulation devices requires rigorous clinical trials and evidence of safety and efficacy. Moreover, educating healthcare providers and patients about the benefits and risks of neurostimulation therapies presents a challenge for manufacturers and healthcare organizations. Additionally, addressing reimbursement issues and healthcare policy considerations poses ongoing challenges for the widespread adoption of neurostimulation treatments.
Government policies support the neurostimulation market through regulatory approvals, reimbursement mechanisms, and investment in medical research to advance neuromodulation therapies for managing chronic pain, neurological disorders, and psychiatric conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neurostimulation Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neurostimulation Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neurostimulation Market - Industry Life Cycle |
3.4 Israel Neurostimulation Market - Porter's Five Forces |
3.5 Israel Neurostimulation Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Neurostimulation Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Neurostimulation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Neurostimulation Market Trends |
6 Israel Neurostimulation Market Segmentations |
6.1 Israel Neurostimulation Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Neurostimulation Market Revenues & Volume, By Spinal Cord Stimulator, 2021-2031F |
6.1.3 Israel Neurostimulation Market Revenues & Volume, By Deep Brain Stimulator, 2021-2031F |
6.1.4 Israel Neurostimulation Market Revenues & Volume, By Sacral Nerve Stimulator, 2021-2031F |
6.1.5 Israel Neurostimulation Market Revenues & Volume, By Vagus Nerve Stimulator, 2021-2031F |
6.1.6 Israel Neurostimulation Market Revenues & Volume, By Gastric Electric Stimulator, 2021-2031F |
6.2 Israel Neurostimulation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Neurostimulation Market Revenues & Volume, By Pain Management, 2021-2031F |
6.2.3 Israel Neurostimulation Market Revenues & Volume, By Epilepsy, 2021-2031F |
6.2.4 Israel Neurostimulation Market Revenues & Volume, By Essential Tremor, 2021-2031F |
6.2.5 Israel Neurostimulation Market Revenues & Volume, By Urinary and Fecal Incontinence, 2021-2031F |
6.2.6 Israel Neurostimulation Market Revenues & Volume, By Depression, 2021-2031F |
6.2.7 Israel Neurostimulation Market Revenues & Volume, By Dystonia, 2021-2031F |
7 Israel Neurostimulation Market Import-Export Trade Statistics |
7.1 Israel Neurostimulation Market Export to Major Countries |
7.2 Israel Neurostimulation Market Imports from Major Countries |
8 Israel Neurostimulation Market Key Performance Indicators |
9 Israel Neurostimulation Market - Opportunity Assessment |
9.1 Israel Neurostimulation Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Neurostimulation Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Neurostimulation Market - Competitive Landscape |
10.1 Israel Neurostimulation Market Revenue Share, By Companies, 2024 |
10.2 Israel Neurostimulation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |